| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1995;92:1223-1229.)
© 1995 American Heart Association, Inc.
Articles |
Correspondence to Dr Qingbo Xu, Section on Gene Expression and Aging, National Institute on Aging, National Institutes of Health, 4940 Eastern Ave, Baltimore, MD 21224.
| Abstract |
|---|
|
|
|---|
Methods and Results Here we provide evidence that restraint-induced hsp70 expression occurs secondary to a rise in systemic blood pressure. Old rats were unable to mount a significant stress-induced hypertensive response, providing an explanation for the reduced hsp70 response in the old rats. A variety of vasoactive agents that induce acute hypertension through distinct signal transduction pathways, including phenylephrine, dopamine, vasopressin, angiotensin II, and endothelin-1, were found to result in hsp70 mRNA induction in the aorta. The magnitude of hsp70 expression achieved with these hypertensive agents was directly correlated with their relative effects on blood pressure. Rats were treated with the vasodilator sodium nitroprusside, which prevented an acute rise in blood pressure from the hypertensive agents tested and abolished induction of hsp70 expression.
Conclusions These findings support the conclusion that hsp70 induction occurs as a physiological response to acute hypertension and suggest the possibility that hsp70 plays a role in the protecting the vasculature from damage during hemodynamic stress.
Key Words: hypertension proteins, heat shock aorta stress
| Introduction |
|---|
|
|
|---|
Most of our knowledge concerning the regulation and function of hsps
has come from studies of cultured
cells.6 7 8 Much less is
known about their expression in vivo, although it is clear that hsps
are induced in the intact animal in response to a variety of
stresses.9 10 11 Recently we
reported12 13 14 that
restraint (immobilization stress) and surgical stress resulted in the
selective induction of hsp70 mRNA and protein in the adrenal cortex and
vasculature of rats. Both tissue responses have been characterized in
detail and have been shown to decline with age. With respect to the
vascular response, we showed that hsp70 induction is confined to the
smooth muscle cell layer of the vessel.13 14
Restraint-induced expression in the aorta could be blocked by
administration of the
1-adrenergic
antagonist prazosin and induced by treatment with the
1-adrenergic agonist phenylephrine,
suggesting that the vascular hsp70 induction in restrained rats is
mediated by means of
1-adrenoceptors.13
Recent studies by others have indicated that the vascular response to
restraint can also be mimicked, at least to some extent, by dopamine
and cocaine.15 16 These agents exert their effects
through
interaction with receptors distinct from the
1-adrenoceptor. Such findings raise the question of
whether the activation of
1-adrenoceptors on smooth
muscle cells during restraint directly leads to activation of the
heat-shock response or whether the hsp expression occurs secondary to
some other receptor-mediated event. Since phenylephrine,
dopamine, and cocaine all can elevate blood pressure, we
examined the relation between blood pressure and vascular hsp70
expression. We demonstrate here that acute hypertension leads to
the induction of hsp70 in rat aorta, and we provide evidence that this
is the mechanism through which restraint elicits this stress response.
In addition, we provide evidence that the age-related attenuation in
vascular hsp70 expression primarily is due to a reduction or absence of
the hypertensive response to restraint.
| Methods |
|---|
|
|
|---|
Blood Pressure Measurements
Rats underwent light anesthesia
with thiopental (40
mg/kg IM) followed by insertion of polyethylene catheters through the
common femoral artery and vein into the abdominal aorta and
inferior vena cava, respectively.13 The aortic
catheter was connected to a pressure transducer (COBE) and a blood
pressure analyzer (Micro-MED, Inc). A bolus injection of
various reagents or saline was administered through the vena caval
catheter, and blood pressure measurements were made every 30 seconds
for 10 or 60 minutes. The doses of the pharmacological agents were
calculated on a microgram per kilogram basis as determined by their
ability to produce consistent hypertensive responses without
demonstrable side effects.
Chronic Catheterization Procedure and Drug
Administration
Polyethylene catheters were inserted through the common
femoral
vein into the inferior vena cava under thiopental (40 mg/kg
IM) anesthesia.13 The catheters were tunneled
through the subcutaneous tissue to exit from the back, where they were
connected to a swivel device (Rodent Multi-fluid Channel Swivel,
Stoelting Co). This model allows for complete rat mobility so that
subsequent experiments could be performed in conscious, unstressed
rats. Saline (0.4 mL) was injected through the catheter daily for 4
days after catheter insertion. Phenylephrine (140 µg/kg),
dopamine (250 µg/kg), vasopressin (2 µg/kg),
angiotensin II (Ang II) (2 µg/kg), and endothelin-1 (1
µg/kg) (Sigma Chemical Co) were administered through the catheter
into the vena cava. For blocking experiments, sodium nitroprusside (600
µg/kg) (Sigma) was injected, followed immediately by the hypertensive
agents at the doses described above. One hour after reagent or saline
administration, the rats were euthanatized and tissues were harvested
for RNA preparation.
Cell Culture
Smooth muscle cells were isolated by enzymatic
digestion of the
aorta from rats according to the procedure of Ross and
Kariya17 and cultured in medium 199 (GIBCO) supplemented
with 20% fetal calf serum, penicillin (100 U/mL), and streptomycin
(100 µg/mL). Cells were incubated at 37°C in a humidified
atmosphere of 95% air/5% CO2. The medium was changed
every 3 days, and cells were passaged by treatment with 0.05%
trypsin/0.02% EDTA solution. Experiments were conducted on smooth
muscle cells (passages 3 through 5) that had just achieved confluence.
Rat serum or various drugs prepared fresh before use were added to the
cultures. After incubation for 1 hour at 37°C, cells were harvested
for RNA analysis.
RNA Extraction and Northern Analysis
Freshly harvested
tissues were homogenized, and the
RNA was extracted by use of RNAzol B (Cinnabiotex). Total RNA (10 µg
per lane) was fractionated by electrophoresis on formaldehyde-agarose
gels and transferred to nylon membranes (Gene Screen Plus, Du Pont Co).
Hybridizations were performed using
-32Plabeled cDNA
hsp70 probe, as previously described.12 Accuracy of
loading and transfer was confirmed by quantitative analysis of
18s and 28s RNA. Autoradiographs of the blots
were obtained in the linear range of detection and were quantified for
the levels of specific expression by scanning laser densitometry
(Molecular Dynamics) of autoradiographs.
Statistical Analysis
ANOVA was performed when more than two
groups were compared.
Paired Student's t test was used to assess differences
between two groups after ANOVA. A value of P<.05 was
considered significant.
| Results |
|---|
|
|
|---|
|
To further establish the relation between
blood pressure and hsp70
expression, we performed a dose-response analysis of
vasopressin-induced hypertension and aortic hsp70 mRNA induction. As in
Fig 2
, blood pressure levels and hsp70 mRNA expression
increased in parallel as a function of the dose of vasopressin.
|
Kinetic
analysis of the hsp70 responses to restraint and
vasopressin treatment is shown in Fig 3
. In the
restraint protocol used for Fig 3A
, rats were left in the
restraint
device for the entire length of time indicated on the x
axis, at which time they were euthanatized and analyzed for
hsp70 expression. In the experiment shown in Fig 3B
, rats were
restrained for the length of time indicated on the x axis
(5, 10, 30, or 60 minutes) then removed and left unrestrained for the
remainder of time: up to 60 minutes after they first were restrained.
As can be seen, the response to both restraint and vasopressin was
rapid, resulting in maximum mRNA levels within 30 minutes of
vasopressin treatment or sustained restraint. As shown in Fig
3B
,
however, the magnitude of induction seen at 60 minutes was dependent on
the length of time the rats were restrained (up to 30 minutes).
Importantly, a short period of restraint (5 minutes) was insufficient
to result in significant hsp70 induction. This is consistent
with the inability of endothelin-1 (which transiently elevated blood
pressure to the same degree as restraint) to induce hsp70 expression.
Thus, for moderate elevations in blood pressure (such as those
occurring with restraint or the dose of endothelin-1 used in the
present study), a sustained elevation in blood pressure is
necessary to achieve maximum hsp70 expression. With higher elevations
of blood pressure (such as those occurring with vasopressin and the
other hypertensive agents used), however, a lesser duration of
hypertension is required.
|
Antihypertensive Agents Can Block HSP70 Expression
The
various agents tested above mediate their effects on
blood pressure by interaction with distinct receptors on the surface of
smooth muscle cells. It was of interest, therefore, to determine
whether hsp70 expression induced by any of these agents could be
prevented by use of a nonspecific vasodilatory agent. Accordingly,
sodium nitroprusside was administered before injection of the
hypertensive agents. As Fig 4A
shows, sodium
nitroprusside alone caused a pronounced decrease in systemic
blood pressure. In addition, it prevented elevation in blood pressure
by vasopressin (Fig 4A
), phenylephrine, Ang II, dopamine,
and endothelin-1 (Fig 4B
). Measurement of hsp70 mRNA levels in
similarly treated rats revealed that sodium nitroprusside uniformly
prevented hsp70 induction in response to these treatments (Fig
4C
).
|
These experiments indicate that induction of
vascular hsp70
expression by restraint and the other agents tested depends on an
elevation in blood pressure. Further support for this notion was
obtained from studies examining the effects of these agents on hsp70
expression in primary aortic smooth muscle cell cultures. We reasoned
that if hsp70 expression were mediated by means of receptor
interactions independent of the effects of these agents on blood
pressure, we would expect to observe induction in the in vitro model,
at least by some of the agents. On the other hand, if induction
occurred secondary to the blood pressure elevation these agents caused,
hsp70 expression would not increase in cultured cells. As Fig 5
shows, no increase in hsp70 expression was observed in
the smooth muscle cell cultures with any of the treatments, although
hsp70 mRNA was strongly induced in these cells in response to heat
treatment. The modest increase was observed in hsp70 mRNA levels in
cultures treated with 20% rat serum (in addition to the 20% fetal
bovine serum in which all cultures were maintained) because hsp70
expression has previously been shown to be elevated in response to
serum. The purpose of this treatment was to determine whether serum
from restrained rats contained a factor that was responsible for hsp70
induction. Because the levels of hsp70 mRNA were similar in cells
treated with serum from unrestrained as well as restrained rats, this
appears not to be the case. These findings, together with the ability
of sodium nitroprusside to prevent induction, argue strongly that hsp70
induction occurs in response to elevated systemic blood pressure.
|
HSP70 Expression in Aorta of Rats Displaying Chronic
Hypertension
In view of the effect of acute elevations in blood
pressure on
hsp70 expression, it was of interest to examine whether expression of
the hsp was affected by chronic hypertension. To address this question,
we examined blood pressure and hsp70 mRNA expression in SHR either left
unrestrained or after being restrained for 1 hour. These rats exhibit
normal blood pressure at birth but spontaneously develop chronic
hypertension with increasing age.18 As shown in Fig
6A
, under non-stress conditions, their systolic
pressure averaged
160 mm Hg, which was similar to that seen in our
Fischer 344 rats subjected to restraint. Restraint resulted in an
elevation in blood pressure to
180 mm Hg. In Fig 6B
, hsp70
mRNA
levels are compared in SHR and WKY rats (the normotensive rat strain
from which SHR were derived) under restraint and not restrained. No
differences were observed in hsp70 expression in the SHR compared with
WKY rats either in the absence of stress or after restraint. Thus,
hsp70 expression appears to depend on acute changes in blood pressure
regardless of the baseline blood pressure level seen in the absence of
stress. These findings suggest that chronic hypertension results in an
adaptation to elevated blood pressure and thus a resetting of the
threshold for hsp70 induction.
|
Correlation of Age-Related Decline in Restraint-Induced hsp70
Expression With Lack of Restraint-Induced Increases in Blood
Pressure
We previously reported13 that the magnitude of
hsp70
mRNA induction in response to restraint was significantly reduced in
old rats compared with young adult rats. In view of the relation
between blood pressure and aortic hsp70 expression established above,
we compared the effect of restraint on blood pressure in young and old
rats (Fig 7A
). Young rats responded to restraint with an
elevation in blood pressure, consistent with the findings
presented in Fig 1
. In contrast, blood pressure did not
increase in old rats during restraint. Next, we determined whether old
rats were able to respond to hypertension-inducing agents with the
induction of hsp70 expression. The effects of optimal doses of
phenylephrine and vasopressin on blood pressure and hsp70
expression were examined. At the dose tested, both agents had a lesser
effect on blood pressure in old compared with young rats (Fig
7B
).
However, on the basis of the dose-response relation for elevated blood
pressure and hsp70 expression established in Fig 2
, the rise in
blood
pressure seen with phenylephrine and vasopressin is
expected to be sufficient to induce hsp70 expression. This is indeed
what we observed (Fig 7C
).
|
| Discussion |
|---|
|
|
|---|
1-adrenoceptors.13 In this article, we
provide new findings that indicate that hsp70 induction in the aorta
occurs not as a primary response to
1-adrenergic
hormone-receptor signal transduction but secondary to acute
hypertension. This conclusion is based on five observations: (1) In
addition to the
1-adrenergic agonist
phenylephrine, four additional agents that act through
distinct receptors to elevate blood pressure all selectively induced
expression of hsp70 mRNA in the rat aorta. (2) The dose-response
relation for the induction of hsp70 mRNA by vasopressin and the
efficacies of the other agents tested for inducing hsp70 were directly
correlated with their relative effects on blood pressure. (3) The
vasodilator sodium nitroprusside, which acts nonspecifically to prevent
increases in blood pressure with each of the above agents, likewise
blocked the induction of hsp70 expression by each. (4) Old rats, which
show less induction of hsp70 in response to restraint, display little
elevation in blood pressure after restraint. (5) This in vivo response
is not observed in vitro when primary cultures of vascular smooth
muscle cells are treated with these agents. Taken together, these
findings support the hypothesis that induction of hsp70 expression in
the aorta occurs as a physiological response to
acute hypertension and suggest the possible involvement of hsp70 either
in protecting the vessel from injury during hemodynamic
stress or in maintaining vascular homeostasis. In agreement with our findings, Moalic et al19 likewise showed that hsp70 mRNA expression was induced in rat aorta after injection with phenylephrine, vasopressin, or Ang II. However, they proposed that the hsp induction occurred as a primary response to the interaction of ligands with specific receptors on the aorta rather than to changes in arterial blood pressure. While we cannot exclude the possibility that direct effects of these agents on the aorta contribute to the response, for the reasons summarized above, they are unlikely to be the main determinant of aortic hsp70 expression in response to the hypertensive agents.
All the agents used in our study increase systemic blood pressure primarily through constriction of peripheral arterioles. This in turn results in stretching of the large arterial wall. While the mechanism of aortic hsp70 mRNA induction remains to be elucidated, we postulate that the induction during acute hypertension may be due to mechanical stress resulting from hemodynamic alterations. This mechanism is consistent with our earlier observation that the response is not restricted to the major arterial vessels but also occurs in the vena cava.13 In addition, it was shown that a single myocardial stretch could induce hsp70 expression in isolated perfused rabbit heart20 and volume overload produced experimentally by banding of the aorta was sufficient to elicit hsp70 induction in the heart.21 However, an in vitro study showed a lack of stretch-induced expression of hsp70 gene in cultured cardiac myocytes,22 suggesting that other factors or subsequent events may be needed for hsp70 induction in the process of cell stretching.
A general feature of the heat-shock response in cultured cells is that it undergoes an attenuation during prolonged treatment with a given stress inducer, which in certain instances is believed to reflect an adaptive response to the stress.23 24 Chronic hypertension may represent a similar situation in vivo: unstressed SHR do not show elevated hsp70 expression even though their basal blood pressures (150 mm Hg) are sufficient to induce the response in WKY rats. However, SHR do show induction with treatments such as restraint, which further elevate their blood pressure above basal levels. Thus, it appears that it is not the absolute blood pressure attained but rather acute fluctuations in blood pressure above basal levels that are responsible for hsp70 induction in aorta.
HSP70 induction in response to restraint is attenuated in old
rats.13 The present study offers an explanation for
this attenuation, ie, that old rats show a lesser hsp70 response
because their blood pressure does not become elevated in response to
restraint. Why blood pressure does not increase in the old rats during
restraint remains to be determined. However, it is important to point
out that this is not because they do not perceive restraint to be
stressful, because in previous studies we measured plasma levels of the
stress hormone corticotropin in old and young rats during restraint and
found it to be similar.13 Instead, we suggest that aging
is accompanied by a reduced responsiveness of the
peripheral vasculature to
1-adrenergic
stimulation. A number of studies have provided evidence for altered
adrenergic function with age.25 26 Furthermore, in
recent
studies in which we have transplanted old vessels into young rats we
have obtained evidence that the loss of responsiveness can be rescued,
at least partially, by such transplantation. Likewise, we have observed
that transplantation of young vessels to old rats leads to a diminished
response.27 These findings suggest that the environment in
which the aorta resides is important in controlling hsp70 induction.
Our proposed model for restraint-induced aortic hsp70 expression as
well as age-related differences in responsiveness of the
peripheral vasculature would account for our findings with
transplanted vessels. Importantly, we have also shown that high doses
of the hypertensive agents used in the present study increase blood
pressure in the old rat, and this is associated with the induction of
hsp70. Even with pharmacological doses of phenylephrine,
however, the elevation in blood pressure was less in old rats compared
with young adult rats, supporting the hypothesis that responsiveness to
1-adrenergic agents declines with age. Finally, we and
others2 28 29 have provided evidence for
a general
age-related decline in the DNA binding activity of the heat-shock
transcription factor HSF1, which mediates the transcriptional
activation of hsp70 in response to stress. While we have not addressed
HSF1 activity in aortic tissue, it is likely that such differences in
HSF1 activity could also contribute to reduced vascular hsp70
expression with age.
Many factors, ranging from physical exertion to drug toxicity, noise, or emotional stress, lead to a rise in blood pressure30 31 that under certain circumstances can lead to severe damage to the vessel wall or even rupture.32 33 Our demonstration that hsp70 expression is markedly increased during acute hypertension suggests a likely role for hsp70 in the host's defense to such hemodynamic stress.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received January 30, 1995; accepted February 27, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X. Zhang, M.-A. He, L. Cheng, L. Zhou, H. Zeng, J. Wang, F. Wang, Y. Chen, F. B. Hu, and T. Wu Joint Effects of Antibody to Heat Shock Protein 60, Hypertension, and Diabetes on Risk of Coronary Heart Disease in Chinese Clin. Chem., June 1, 2008; 54(6): 1046 - 1052. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, A.-P. Arrigo, and R. W. Currie Heat shock treatment suppresses angiotensin II-induced activation of NF-{kappa}B pathway and heart inflammation: a role for IKK depletion by heat shock? Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1104 - H1114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayr, Y.-L. Chung, U. Mayr, E. McGregor, H. Troy, G. Baier, M. Leitges, M. J. Dunn, J. R. Griffiths, and Q. Xu Loss of PKC-{delta} alters cardiac metabolism Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H937 - H945. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mayr, B. Metzler, Y.-L. Chung, E. McGregor, U. Mayr, H. Troy, Y. Hu, M. Leitges, O. Pachinger, J. R. Griffiths, et al. Ischemic preconditioning exaggerates cardiac damage in PKC-{delta} null mice Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H946 - H956. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okada, N. Hasebe, Y. Aizawa, K. Izawa, J.-i. Kawabe, and K. Kikuchi Thermal Treatment Attenuates Neointimal Thickening With Enhanced Expression of Heat-Shock Protein 72 and Suppression of Oxidative Stress Circulation, April 13, 2004; 109(14): 1763 - 1768. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Mawji, G. B. Robb, S. C. Tai, and P. A. Marsden Role of the 3'-Untranslated Region of Human Endothelin-1 in Vascular Endothelial Cells: CONTRIBUTION TO TRANSCRIPT LABILITY AND THE CELLULAR HEAT SHOCK RESPONSE J. Biol. Chem., March 5, 2004; 279(10): 8655 - 8667. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Wernig, M. Mayr, and Q. Xu Mechanical Stretch-Induced Apoptosis in Smooth Muscle Cells Is Mediated by {beta}1-Integrin Signaling Pathways Hypertension, April 1, 2003; 41(4): 903 - 911. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu Role of Heat Shock Proteins in Atherosclerosis Arterioscler. Thromb. Vasc. Biol., October 1, 2002; 22(10): 1547 - 1559. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. Schmitt, H. Schunkert, D.E. Birnbaum, and H. Aebert Kinetics of heat shock protein 70 synthesis in the human heart after cold cardioplegic arrest Eur. J. Cardiothorac. Surg., September 1, 2002; 22(3): 415 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Mayr, M. Mayr, C. Li, F. Wernig, H. Dietrich, Y. Hu, and Q. Xu Loss of p53 Accelerates Neointimal Lesions of Vein Bypass Grafts in Mice Circ. Res., February 8, 2002; 90(2): 197 - 204. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ishizaka, T. Aizawa, M. Ohno, S.-i. Usui, I. Mori, S.-S. Tang, J. R. Ingelfinger, S. Kimura, and R. Nagai Regulation and Localization of HSP70 and HSP25 in the Kidney of Rats Undergoing Long-Term Administration of Angiotensin II Hypertension, January 1, 2002; 39(1): 122 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. K. Kanwar, J. R. Kanwar, D. Wang, D. J. Ormrod, and G. W. Krissansen Temporal Expression of Heat Shock Proteins 60 and 70 at Lesion-Prone Sites During Atherogenesis in ApoE-Deficient Mice Arterioscler. Thromb. Vasc. Biol., December 1, 2001; 21(12): 1991 - 1997. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. H. E. H. Snoeckx, R. N. Cornelussen, F. A. Van Nieuwenhoven, R. S. Reneman, and G. J. Van der Vusse Heat Shock Proteins and Cardiovascular Pathophysiology Physiol Rev, October 1, 2001; 81(4): 1461 - 1497. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chang, J. S. Wasser, R. N.M. Cornelussen, and A.A. Knowlton Activation of Heat-Shock Factor by Stretch-Activated Channels in Rat Hearts Circulation, July 10, 2001; 104(2): 209 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hammerer-Lercher, J. Mair, J. Bonatti, S. B.C. Watzka, B. Puschendorf, and S. Dirnhofer Hypoxia induces heat shock protein expression in human coronary artery bypass grafts Cardiovasc Res, April 1, 2001; 50(1): 115 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Burian, Z. Kis, D. Virok, V. Endresz, Z. Prohaszka, J. Duba, K. Berencsi, K. Boda, L. Horvath, L. Romics, et al. Independent and Joint Effects of Antibodies to Human Heat-Shock Protein 60 and Chlamydia pneumoniae Infection in the Development of Coronary Atherosclerosis Circulation, March 20, 2001; 103(11): 1503 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Xu, G. Schett, C. Li, Y. Hu, and G. Wick Mechanical Stress-Induced Heat Shock Protein 70 Expression in Vascular Smooth Muscle Cells Is Regulated by Rac and Ras Small G Proteins but Not Mitogen-Activated Protein Kinases Circ. Res., June 9, 2000; 86(11): 1122 - 1128. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Li, Y. Hu, G. Sturm, G. Wick, and Q. Xu Ras/Rac-Dependent Activation of p38 Mitogen-Activated Protein Kinases in Smooth Muscle Cells Stimulated by Cyclic Strain Stress Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20 (3): e1 - e9. [Abstract] [Full Text] [PDF] |
||||
![]() |
B.-W. Hochleitner, E.-O. Hochleitner, P. Obrist, T. Eberl, A. Amberger, Q. Xu, R. Margreiter, and G. Wick Fluid Shear Stress Induces Heat Shock Protein 60 Expression in Endothelial Cells In Vitro and In Vivo Arterioscler. Thromb. Vasc. Biol., March 1, 2000; 20(3): 617 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. MAYR, C. LI, Y. ZOU, U. HUEMER, Y. HU, and Q. XU Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases FASEB J, February 1, 2000; 14(2): 261 - 270. [Abstract] [Full Text] |
||||
![]() |
D.-F. Liao, Z.-G. Jin, A. S. Baas, G. Daum, S. P. Gygi, R. Aebersold, and B. C. Berk Purification and Identification of Secreted Oxidative Stress-induced Factors from Vascular Smooth Muscle Cells J. Biol. Chem., January 7, 2000; 275(1): 189 - 196. [Abstract] [Full Text] [PDF] |
||||